Meta-analysis of Clinical Efficacy of Acupoint Injection for Nape-back Fasciitis
10.13359/j.cnki.gzxbtcm.2018.02.033
- VernacularTitle:穴位注射治疗项背肌筋膜炎临床疗效的Meta分析
- Author:
Rui ZHOU
1
;
Li-Xing ZHUANG
;
Ke-Song LI
;
Jun HE
Author Information
1. 广州中医药大学针灸康复临床医学院
- Keywords:
nape-back fasciitis;
acupoint injection therapy;
platelet aggregation;
thromboxan A2;
Meta-analysis
- From:
Journal of Guangzhou University of Traditional Chinese Medicine
2018;35(2):357-363
- CountryChina
- Language:Chinese
-
Abstract:
Objective To assess the clinical curative effect of acupoint injection for the treatment of nape-back fasciitis by Meta-analysis, thus to provide evidence for the treatment of nape-back fasciitis. Methods A retrieval of literatures concerning treatment of nape-back fasciitis with acupoint injection was carried out in the databases of Cochrane Library, PubMed, CMB, CNKI, Wanfang and VIP. Review Manager 5.3 software was used for the evaluation of methodological quality and bias risk of the included randomized controlled trials(RCT) which met the enrolling requirements. At the same time, Meta-analysis was carried out for the main outcome measure of effective rate and the secondary outcome measures of platelet aggregation rate and thromboxan A2 (TXA2) level. Results A total of 10 RCT involving 833 cases were included. The results showed that the treatment group had higher effective rate than the control group (OR = 7.21, 95％ CI [ 4.16, 12.49] , in the combined effect test Z = 7.04) , and the difference was significant(P < 0.01); the treatment group had better effect on decreasing the platelet aggregation rate {mean difference(MD) being 2.50, 95％ CI [1.34, 3.66], Z =4.23} and on reducing the level of TXA2 (MD = 33.35, 95％CI [22.97, 43.72], Z = 6.30) than the control group, the difference being significant (P < 0.01). Conclusion Acupoint injection exerts certain therapeutic effect for the treatment of nape-back fasciitis, and its effect on reducing blood inflammatory factors is better than that of acupuncture or drug therapy alone. However, due to the small quantity and low quality of the included studies, more large-sample, multi-center and high-quality clinical studies are needed to validate the results.
